Patents by Inventor Taisuke MOCHIDA

Taisuke MOCHIDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210254014
    Abstract: The present invention relates to a method for producing an insulin-producing cell population or a pancreatic ? cell population having the reduced number of Ki67-positive cells, comprising treating a population of endocrine progenitor cells or cells at a later stage of differentiation with an FGFR1 inhibitor.
    Type: Application
    Filed: April 22, 2019
    Publication date: August 19, 2021
    Applicants: Kyoto University, Takeda Pharmaceutical Company Limited
    Inventors: Noriko YAMAZOE, Hideyuki HIYOSHI, Taisuke MOCHIDA, Ryo ITO, Taro TOYODA, Azuma KIMURA
  • Publication number: 20210060210
    Abstract: An object of the present invention is to provide a method for removing highly proliferative Ki67-positive cells co-present in insulin-secreting cells obtained by differentiation induction. A method for producing an insulin-producing cell population or a pancreatic beta cell population containing less than 3% of Ki67-positive cells, comprising: embedding an endocrine progenitor cell population or a cell population at a later stage of differentiation into a gel containing alginic acid; and differentiating the cell population.
    Type: Application
    Filed: March 18, 2019
    Publication date: March 4, 2021
    Applicants: Kyoto University, Takeda Pharmaceutical Company Limited
    Inventors: Taro TOYODA, Taisuke MOCHIDA, Yutaka TANOUE, Ryo ITO, Koya KIMOTO, Yusuke KOIKE, Hikaru UENO